Suppr超能文献

[乳腺癌组织提取物中组织型纤溶酶原激活物(t-PA)的浓度]

[The concentration of tissue--type plasminogen activator (t-PA) in extracts of breast cancer tissue].

作者信息

Ziółkowska Ewa, Pietrusińska Elzbieta, Łozyńska-Podhrebelna Diana

机构信息

Centrum Onkologii w Bydgoszczy, Oddział Radioterapii.

出版信息

Pol Merkur Lekarski. 2008 Dec;25(150):489-94.

Abstract

UNLABELLED

Degradation of the extracellular matrix metalloproteinases, which are activated mainly by the plasmin (the key enzyme of the fibrinolysis system), is the basis of the invasion of breast cancer cells. The tissue plasminogen activator (t-PA), a specific serine protease, is one of the plasmin activators. Shifting the balance between factors stimulating and inhibiting angiogenesis within the tumour microenvironment it influences negatively the progression of breast cancer. The aim of the study was to estimate the concentration of t-PA levels in breast cancer tissue extracts in comparison with normal breast tissues as well as to analyze the t-PA level changes in relation to "classical" prognostic factors.

MATERIAL AND METHODS

A total number of 30 breast cancer patients aged from 39-79 (mean 58) years entered the study. According to the TNM system the pathological stage of the disease was assessed and the estrogen (ER) and progesterone (PgR) receptor status was determined for each patient. Additionally, in ten patients aged from 29-44 (mean 33) years the level of the t-PA in benign breast tissue lesions was determined. The studied tissues were obtained during surgery. Macroscopically normal tissues, which were located 2 cm from the tumor, served as a controls group. Levels of the t-PA were determined using the enzyme-linked immunosorbent assay (ELISA).

RESULTS

The study showed no statistically significant difference between the levels of the t-PA in tumors and in normal tissues. In terms of prognostic factors t-PA level was significantly higher in cancer tissues obtained from patients with no lymph node metastases as well as in tumors containing progesterone receptors. The PgR levels were significantly higher in benign breast lesions in comparison with both, normal tissues and tumors.

CONCLUSIONS

The study showed a significant relationship between the high level of t-PA and a favorable prognosis estimated on the basis of "classical" prognostic factors.

摘要

未标记

细胞外基质金属蛋白酶的降解是乳腺癌细胞侵袭的基础,这些蛋白酶主要由纤溶酶(纤维蛋白溶解系统的关键酶)激活。组织纤溶酶原激活物(t-PA)是一种特异性丝氨酸蛋白酶,是纤溶酶激活物之一。它通过改变肿瘤微环境中刺激和抑制血管生成的因素之间的平衡,对乳腺癌的进展产生负面影响。本研究的目的是评估乳腺癌组织提取物中t-PA水平与正常乳腺组织相比的浓度,并分析t-PA水平与“经典”预后因素的关系。

材料与方法

共有30名年龄在39至79岁(平均58岁)的乳腺癌患者进入研究。根据TNM系统评估疾病的病理分期,并确定每位患者的雌激素(ER)和孕激素(PgR)受体状态。此外,在10名年龄在29至44岁(平均33岁)的患者中,测定了良性乳腺组织病变中t-PA的水平。研究组织在手术期间获取。距离肿瘤2厘米处的宏观正常组织作为对照组。使用酶联免疫吸附测定(ELISA)测定t-PA的水平。

结果

研究表明,肿瘤组织和正常组织中t-PA水平之间无统计学显著差异。就预后因素而言,在无淋巴结转移患者的癌组织以及含有孕激素受体的肿瘤中,t-PA水平显著更高。与正常组织和肿瘤相比,良性乳腺病变中的PgR水平显著更高。

结论

研究表明,t-PA高水平与基于“经典”预后因素估计的良好预后之间存在显著关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验